Back to mobile site
Get it on Google Play

Obsidian Therapeutics to present melanoma therapy data at SITC 2026

October 2, 2026 9:05 AM EDT Send to a Friend
Obsidian Therapeutics (Nasdaq: OBX) announced it will present updated clinical data on its investigational cell therapy amsokigene autoleucel (amsoki-cel) at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login